NCT01518855View on ClinicalTrials.gov

Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

514

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
Hypertension
Interventions
DRUG

Nifedipine (Adalat, BAYA1040)

DRUG

Amlodipine (Norvasc)

DRUG

Diovan

Trial Locations (4)

733-0011

Hiroshima

060-0003

Sapporo

158-0097

Setagaya-ku

163-6003

Shinjuku-ku

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY